Could low-risk criteria slow down Integrated Pest Management? Biocontrol Coalition publishes new background note

November 2026

In our background note, “Could ‘low-risk criteria’ slow down Integrated Pest Management (IPM)?”, the Biocontrol Coalition explains how restricting accelerated authorisation procedures under the Food and Feed Safety Omnibus (Omnibus X) to substances meeting the criteria in Annex II, pt 5 of Reg. (EC) 1107/2009 could counterintuitively limit farmers’ access to crop protection solutions that advance Integrated Pest Management (IPM).

The note explains why facilitating access to biocontrol products does not mean compromising safety standards. Biocontrol products are not considered safe simply because they qualify as biocontrol. They must meet the applicable scientific and regulatory safety requirements, just like other plant protection products.

Biocontrol and low-risk: why the distinction matters

Ongoing discussions on Omnibus X have raised questions about whether measures to accelerate the authorisation of plant protection products should be reserved for substances meeting the criteria set out in Annex II, point 5 of Regulation (EC) No 1107/2009. However, these criteria are primarily hazard-based and do not necessarily reflect the actual risks associated with a product, particularly when appropriate risk mitigation measures are available.

The European Commission’s original Omnibus X proposal takes a different approach, allowing Member States to grant provisional authorisations to products containing biocontrol substances where the draft assessment indicates compliance with the relevant safety and efficacy requirements under the Plant Protection Regulation.

The Annex II “low-risk” criteria could exclude the majority of biocontrol solutions

The Coalition’s background note provides concrete examples of how applying the low-risk criteria as a strict condition for accelerated authorisation could exclude biocontrol products despite their compliance with applicable safety requirements.

For instance, sensitisation is among the exclusion criteria, even though associated risks may be managed through protective equipment or measures limiting exposure. Moreover, the absence of validated methods for assessing sensitisation in microorganisms means that such biological substances are often flagged as “possible” sensitisers by default due to the impossibility to generate data demonstrating otherwise.

As recently highlighted by IFOAM Organics Europe, substances such as garlic extract and orange oil could be excluded from acceleration measures because the criteria and data requirements are not tailored to biocontrol.

The potential impact could be significant. According to an analysis by the International Biocontrol Manufacturers Association (IBMA), up to 58% of biocontrol products already on the EU market might not have qualified for accelerated registration under a low-risk-only approach, due to sensitisation issues or the absence of suitable testing methods.

Supporting innovation while maintaining safety

Improving access to biocontrol solutions is an important part of strengthening Integrated Pest Management and expanding the range of crop protection tools available to European farmers.

The Coalition therefore emphasises that eligibility for accelerated procedures should not be restricted exclusively to substances meeting the low-risk criteria. Instead, Omnibus X should recognise the specific characteristics of biocontrol while ensuring that all products continue to meet the EU’s established safety requirements.

By maintaining a science-based approach to authorisation, the EU can support innovation, facilitate access to a broader range of crop protection solutions and strengthen Integrated Pest Management while ensuring high standards for human health or environmental protection.